Markets for Advanced Wound Care Technologies
October 24, 2011
Wellesley, Mass. – In a recent release, MARKETS FOR ADVANCED WOUND CARE TECHNOLOGIES (PHM011G) from BCC Research (www.bccresearch.com), the U.S. market for advanced wound care is estimated to reach $3.6 billion in 2011 and nearly $4.6 billion by 2016 at a compound annual growth rate (CAGR) of 4.9%.
The total market for advanced wound care technologies can be broken down into two segments – wound care dressings, sealants, and anti-adhesion products, and wound healing devices and equipment.
The segment made up of dressings, sealants and anti-adhesion products was worth nearly $2.2 billion in 2011 and in 2016 should be worth $3 billion, a CAGR of 7%.
The segment composed of healing devices and equipment, worth $1.4 billion in 2011, should be worth $1.5 billion in 2016, a CAGR of 1.2%.
Advanced wound care deals with those products that involve new techniques and therapies, are of benefit in healing wounds, and result in overall lower costs for care. They incorporate biotechnological advancements and improved methods for treating wounds.
Recent trends have shown that new technological products are competing in a fast-track market that seeks to improve the quality of life for millions of individuals needing both acute and chronic wound care.
Three general areas are discussed in this report: acute wounds, chronic wounds, and burn wounds. These encompass five market segments: biological dressings, surgical sealants and glues, synthetic dressings, other wound healing products, and wound healing devices
Markets for Advanced Wound Care Technologies( PHM011G )
Publish Date: Oct 2011
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Pharmaceuticals
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Global GLP-1 Analogues Market to Reach $268.4 Billion by 2030
- AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast
Reports from Pharmaceuticals
Recent News
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand